Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis

NCT00997815 is registered in ClinicalTrials.gov with Siriraj Hospital as lead sponsor.

NCT NCT00997815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00997815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis
Lead sponsor
Siriraj Hospital
Phase
Phase 2/3
Overall status
Completed
Start date
December 31, 2009
Completion date
June 30, 2011
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recalcitrant alopecia totalis, recalcitrant alopecia universalis